Your browser doesn't support javascript.
loading
A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study.
Lapointe, Sarah; Mason, Warren; MacNeil, Mary; Harlos, Craig; Tsang, Roger; Sederias, Joana; Luchman, H Artee; Weiss, Samuel; Rossiter, John P; Tu, Dongsheng; Seymour, Lesley; Smoragiewicz, Martin.
Afiliação
  • Lapointe S; Division of Neurology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
  • Mason W; Division of Neuro-Oncology, Pencer Brain Tumor Center, University Health Network-Princess Margaret Hospital, Toronto, ON, Canada.
  • MacNeil M; Division of Neuro-Oncology, Pencer Brain Tumor Center, University Health Network-Princess Margaret Hospital, Toronto, ON, Canada.
  • Harlos C; QEII Health Sciences Centre, Halifax, NS, Canada.
  • Tsang R; CancerCare Manitoba, Winnipeg, MB, Canada.
  • Sederias J; Tom Baker Cancer Center, Calgary, AB, Canada.
  • Luchman HA; Canadian Cancer Trials Group, Queen's University, Kingston, ON, K7L3N6, Canada.
  • Weiss S; Arnie Charbonneau Cancer Institute & Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Rossiter JP; Arnie Charbonneau Cancer Institute & Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Tu D; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
  • Seymour L; Canadian Cancer Trials Group, Queen's University, Kingston, ON, K7L3N6, Canada.
  • Smoragiewicz M; Canadian Cancer Trials Group, Queen's University, Kingston, ON, K7L3N6, Canada.
Invest New Drugs ; 38(4): 1137-1144, 2020 08.
Article em En | MEDLINE | ID: mdl-31707687
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Benzamidas / Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Morfolinas / Glioblastoma / Alvo Mecanístico do Complexo 1 de Rapamicina / Alvo Mecanístico do Complexo 2 de Rapamicina / Temozolomida / Antineoplásicos Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Benzamidas / Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Morfolinas / Glioblastoma / Alvo Mecanístico do Complexo 1 de Rapamicina / Alvo Mecanístico do Complexo 2 de Rapamicina / Temozolomida / Antineoplásicos Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá